HODGKIN'S DISEASE IN TURKISH CHILDREN: Clinical Characteristics and Treatment Results of 210 Patients

References

• Gutensohn N, Cole P. Chilhood social environment and Hodgkin's disease. N Eng1J Med. 1981;304: 5–40.
   PubMedGoogle Scholar
• Gad El-Mawla N, El-Deeb BB, Abu-Gabal A, et al. Pediatric Hodgkin's disease in Egypt. Cancer. 1983;52:1129–1131.
   PubMedGoogle Scholar
• Medeiros LJ, Greiner TC. Hodgkin's disease. Cancer. 1995;75:357–369.
   PubMed Web of Science ®Google Scholar
• Kolygin BA. Hodgkin's disease in children: a retrospective study of the 20-year experience (1968-1987) at a single institute. Med Pediatr Oncol. 1995;25:407–413.
   PubMedGoogle Scholar
• Jacobs P, King HS, Karabus C, et al. Hodgkin's disease in children: a ten-year experience in South Africa. Cancer. 1984;53:210–213.
   PubMed Web of Science ®Google Scholar
• Faria SL, Vassallo J, Cosset JM, Bradalise SR. Childhood Hodgkin's disease in Compinas, Brazil. Med Pediatr Oncol. 1996;26:90–94.
   PubMedGoogle Scholar
• Oberlin 0, Leverger G, Pacqument H, et al. Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology. J Gan Oncol. 1992;10: 1602–1608.
   Google Scholar
• Vecchi V, Burnelli R, Fabio S, et al. Childhood Hodgkin's disease: results of the Italian multicentric study AIEOP-MH'89-CNR. Third International Symposium on Hodgkin's Lymphoma, 18–23 Septem-ber 1995, Köln, Germany, p 191 (abstr).
   Google Scholar
• Donaldson SS, Link MP. Combined modality treatment with low-dose radiation and MOPP chemother-apy for children with Hodgkin's disease. J Clin Oncol. 1987;5:742–749.
   PubMed Web of Science ®Google Scholar
• Hunger SP, Link MP, Donaldson SS. ABVD/MOPP and low-dose involved-field radiotherapy in pedi-atric Hodgkin's disease: the Stanford Experience. J Clin Oncol. 1994;12:2160–2166.
   Google Scholar
• Hudson MM, Greenwald C, Thompson E, et al. Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease. J Clin Oncol. 1993;11:100–108.
   PubMed Web of Science ®Google Scholar
• Donaldson SS, Whitaker SJ, Plowmann PN, et al. Stage I-II pediatric Hodgkin's disease: long-term follow-up demonstrates equivalent survival rates following different management schemes. J Clin Oncol. 1990;8:1128–1137.
   PubMed Web of Science ®Google Scholar
• Carbone PP, Kaplan HS, Musskoff K, et al. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971;31:1860–1861.
   PubMed Web of Science ®Google Scholar
• Lukes RJ, Butler JJ. The pathology and nomenclature of Hodgkin's disease. Cancer Res. 1966;26:1063–1081.
   PubMed Web of Science ®Google Scholar
• DeVita VT Jr, Serpick AA, Carbone PP. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med. 1970;73:891–895.
   Google Scholar
• Kaplan ES, Meier P. Non-parametric estimation from incomplete observations. Am Stat Assoc J. 1958;53A:457–480.
   Google Scholar
• Peto R, Pike MC, Armitage P. et al. Design and analysis of randomised clinical trials requiring pro-longed observation for each patient, II: analysis and examples. Br J Cancer. 1977;35:1–39.
   Google Scholar
• Hiçsönmez G, Bilyökpamukçu M. Pediatric hematology and oncology in Turkey. Ph/o Forum. 1994;1: 4–8.
   Google Scholar
• Correa P, O'Conor GT. Epidemiologic pattern of Hodgkin's disease. IntJ Cancer. 1971;8:192–201.
   PubMed Web of Science ®Google Scholar
• Cleary SF, Link MP, Donaldson SS. Hodgkin's disease in the very young. Int J Radiat Oncol Biol Ploys. 1993;28:77–83.
   Google Scholar
• Parkes SE, Goad NAG, Muir KR, et al. Hodgkin's disease in children in the West Midlands, 1957-1986: a large population-based study. Pediatr Hem atol Oncol. 1994;11:471–486.
   PubMed Web of Science ®Google Scholar
• cavdar AO, Yavuz G, Babacan E, et al. Burkitt's lymphoma in Turkish children: clinical, viral (EBV) and molecular studies. Leuk Lymphoma. 1994;14:323–330.
   PubMedGoogle Scholar
• Weiss LM, Strickler JG, Warnke RA, et al. Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am J PathoL 1987;129:86–91.
   PubMed Web of Science ®Google Scholar
• Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS. Expression of Epstein-Barr virus latent gene products in tumor cells of Hodgkin's disease. Lancet 1991;337:320–322.
   PubMed Web of Science ®Google Scholar
• Jarrett RF, Gallagher A, Jones DB, et al. Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age. J Clin PathoL 1991;44:844–848.
   PubMed Web of Science ®Google Scholar
• Weiss LM, Chen YY, Liu XF, Shibata D. Epstein-Barr virus and Hodgkin's disease: a correlative insitu hybridization and polymerase chain reaction study. Am JPathoL 1991;139:1259–1265.
   PubMed Web of Science ®Google Scholar
• Pamir A, cavdar AO, Von tanthen R, et al. Epstein-Barr virus latent membrane protein expression and distribution of viral subtypes in Turkish Hodgkin's disease: a comparative study with non-neoplastic lymphoid hyperplasia. Med Pediatr OncoL 1995;25:260 (abstr).
   Google Scholar
• cevik N, Bilyilkpamukçu M, Sarialioglu F, et al. Experience in the management of childhood H odgkin's disease. Proceedings of the 15th International Congress of Chemotherapy, Istanbul, Turkey, 19–24 July 1987, p 648–650.
   Google Scholar
• Matawy MS, Omar YT. Hodgkin's disease in children in Kuwait. Cancer. 1986;57:2255–2259.
   PubMedGoogle Scholar
• Dinshaw KA, Panda S, Advani S, et al. Pediatric Hodgkin's disease in India. J Clin Oncol. 1985;3:1605–1612.
   PubMedGoogle Scholar
• Shankar AG, Ashley S, Radford M, Barrett A, Wright D, Pinkerton CR. Does histology influence outcome in childhood Hodgkin's disease? Results from the United Kingdom Children's Cancer Study Group. J Clin Oncol. 1997;15:2622–2630.
   PubMedGoogle Scholar
• Weinshel EL, Peterson BA. Hodgkin's disease. CA Cancer.' Clin. 1993;43:327–346.
   PubMedGoogle Scholar
• Mockonko K, Fejes M, Breazavscak DM, et al. The relation between EBV antibodies clinical symp-tomatology and immune deficiency in patients with Hodgkin's disease. Cancer. 1979;44:2065–2070.
   PubMedGoogle Scholar
• Tekinalp G, cevik N, Bilyfilpamukçu M. Hodgkin lenfomalivakalarda serum ye doku cinko diizeyleri. Cocuk Sagligi ve Hastaliklari Dergisi. 1985;28:275–281.
   Google Scholar
• cavdar AO, Babacan E, Gözdasoglu S, et al. Zinc and anergy in pediatric Hodgkin's disease in Tfirkiye. Cancer. 1987;59:305–309.
   Google Scholar
• Herman TS, Hoppe RT, Donaldson SS, et al. Late relapse among patients treated for Hodgkin's disease. Ann Intern Med. 1985;102:292–297.
   PubMed Web of Science ®Google Scholar
• Ilhan I, Sarialioglu F, özbarlas N, et al. Late cardiac effects after treatment for childhood Hodgkin's disease with chemotherapy and low-dose radiotherapy. Postgrad Med J. 1995;71:164–167.
   Google Scholar
• Ilhan I, Sarialioglu F, Bilgiç H, et al. Long-term pulmonary function in children with Hodgkin's disease. Acta Pediatr. 1996;85:324–326.
   Google Scholar
• Wiliams J, Thompson E, Smith KL. Long-term results of treatment of children and adolescents with Hodgkin's disease. Cancer. 1980;46:2123–2125.
   Google Scholar
• Kaldor JM, Day NE, Clarke A, et al. Leukemia following Hodgkin's disease. N Eng1J Med. 1990;322: 7–13.
   PubMed Web of Science ®Google Scholar
• Bhatia S, Robison LL, Oberlin 0, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Eng1J Med. 1996;334: 745–751.
   Google Scholar